{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:06:11Z","timestamp":1791770771768,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601718"],"award-info":[{"award-number":["81601718"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872024"],"award-info":[{"award-number":["81872024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073300"],"award-info":[{"award-number":["82073300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.yexcr.2021.112755","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T11:59:52Z","timestamp":1627559992000},"page":"112755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells"],"prefix":"10.1016","volume":"406","author":[{"given":"Liangbo","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9389-723X","authenticated-orcid":false,"given":"Mingzhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengtian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8708-6171","authenticated-orcid":false,"given":"Jiqin","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yexcr.2021.112755_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-017-0712-x","article-title":"The biology of Hepatocellular carcinoma: implications for genomic and immune therapies","volume":"16","author":"Khemlina","year":"2017","journal-title":"MOL CANCER"},{"key":"10.1016\/j.yexcr.2021.112755_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejrad.2017.08.030","article-title":"Primary malignant tumours in the non-cirrhotic liver","volume":"95","author":"Lee","year":"2017","journal-title":"Eur. J. Radiol."},{"issue":"4","key":"10.1016\/j.yexcr.2021.112755_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2021.112755_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.canlet.2015.11.034","article-title":"MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS\/RAF\/ERK signaling pathways","volume":"371","author":"Xu","year":"2016","journal-title":"CANC. LETT."},{"issue":"7","key":"10.1016\/j.yexcr.2021.112755_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.kjms.2018.03.006","article-title":"Increased cumulative doses and appearance of hand-foot skin reaction prolonged progression free survival in sorafenib-treated advanced hepatocellular carcinoma patients","volume":"34","author":"Chang","year":"2018","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"8","key":"10.1016\/j.yexcr.2021.112755_bib6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/onc.2017.368","article-title":"Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia","volume":"37","author":"Peng","year":"2018","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.yexcr.2021.112755_bib7","first-page":"1391","article-title":"Reversal of the Warburg effect with DCA in PDGFtreated human PASMC is potentiated by pyruvate dehydrogenase kinase1 inhibition mediated through blocking Akt\/GSK3beta signalling","volume":"42","author":"Li","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.yexcr.2021.112755_bib8","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.21873\/anticanres.12981","article-title":"Coupling dichloroacetate treatment with Curcumin significantly enhances anticancer potential","volume":"38","author":"Kan","year":"2018","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.yexcr.2021.112755_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/bjc.2012.559","article-title":"Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma","volume":"108","author":"Shen","year":"2013","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.yexcr.2021.112755_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.freeradbiomed.2014.02.012","article-title":"HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway","volume":"70","author":"Ni","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"24","key":"10.1016\/j.yexcr.2021.112755_bib11","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.yexcr.2021.112755_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1476-4598-10-142","article-title":"Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells","volume":"10","author":"Sun","year":"2011","journal-title":"MOL CANCER"},{"issue":"5","key":"10.1016\/j.yexcr.2021.112755_bib13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1158\/1078-0432.CCR-15-0663","article-title":"Sorafenib inhibition of mcl-1 accelerates ATRA-induced apoptosis in differentiation-responsive AML cells","volume":"22","author":"Wang","year":"2016","journal-title":"Clin. Canc. Res."},{"issue":"21","key":"10.1016\/j.yexcr.2021.112755_bib14","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/1078-0432.CCR-18-0549","article-title":"Tyrosine kinase inhibitors increase MCL1 degradation and in combination with BCLXL\/BCL2 inhibitors drive prostate cancer apoptosis","volume":"24","author":"Arai","year":"2018","journal-title":"Clin. Canc. Res."},{"issue":"10","key":"10.1016\/j.yexcr.2021.112755_bib15","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1158\/1535-7163.MCT-12-0093","article-title":"Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species Production In vitro and in","volume":"11","author":"Coriat","year":"2012","journal-title":"Vivo. Mol. Canc. Ther."},{"key":"10.1016\/j.yexcr.2021.112755_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.bbrc.2020.10.083","article-title":"Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis","volume":"534","author":"Li","year":"2021","journal-title":"Biochem. Bio. Res. Co."},{"key":"10.1016\/j.yexcr.2021.112755_bib17","doi-asserted-by":"crossref","first-page":"113728","DOI":"10.1016\/j.bcp.2019.113728","article-title":"JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells","volume":"171","author":"Heslop","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2021.112755_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.freeradbiomed.2019.01.008","article-title":"Redox biology of regulated cell death in cancer: a focus on necroptosis and ferroptosis","volume":"134","author":"Florean","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.yexcr.2021.112755_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2217\/hep.15.27","article-title":"Apoptosis in liver carcinogenesis and chemotherapy","volume":"2","author":"Moreno-Caceres","year":"2015","journal-title":"Hepat Oncol"},{"issue":"3","key":"10.1016\/j.yexcr.2021.112755_bib20","doi-asserted-by":"crossref","first-page":"e173712","DOI":"10.1371\/journal.pone.0173712","article-title":"Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS","volume":"12","author":"Qu","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.yexcr.2021.112755_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00109-012-0966-0","article-title":"Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma","volume":"91","author":"Guo","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"4","key":"10.1016\/j.yexcr.2021.112755_bib22","doi-asserted-by":"crossref","first-page":"e92962","DOI":"10.1371\/journal.pone.0092962","article-title":"Dichloroacetate enhances adriamycin-induced hepatoma cell toxicity in vitro and in vivo by increasing reactive oxygen species levels","volume":"9","author":"Dai","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.yexcr.2021.112755_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/bjc.2013.334","article-title":"Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)\/Akt signaling","volume":"109","author":"Wan","year":"2013","journal-title":"Br. J. Canc."},{"issue":"15","key":"10.1016\/j.yexcr.2021.112755_bib24","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/bloodadvances.2018022392","article-title":"Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis","volume":"2","author":"Nayak","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.yexcr.2021.112755_bib25","doi-asserted-by":"crossref","first-page":"8201079","DOI":"10.1155\/2019\/8201079","article-title":"Dichloroacetate (DCA) and cancer: an overview towards clinical applications","volume":"2019","author":"Tataranni","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"issue":"7","key":"10.1016\/j.yexcr.2021.112755_bib26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","article-title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br. J. Canc."},{"issue":"10","key":"10.1016\/j.yexcr.2021.112755_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.12998\/wjcc.v4.i10.336","article-title":"Long-term stabilization of stage 4 colon cancer using sodium dichloroacetate therapy","volume":"4","author":"Khan","year":"2016","journal-title":"World J. Clin. Cases"},{"issue":"5","key":"10.1016\/j.yexcr.2021.112755_bib28","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1542\/peds.2005-1226","article-title":"Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children","volume":"117","author":"Stacpoole","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.yexcr.2021.112755_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ymgme.2013.03.019","article-title":"Long-term safety of dichloroacetate in congenital lactic acidosis","volume":"109","author":"Abdelmalak","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"9\u201310","key":"10.1016\/j.yexcr.2021.112755_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.18632\/genesandcancer.155","article-title":"JNK-signaling: a multiplexing hub in programmed cell death","volume":"8","author":"Dhanasekaran","year":"2017","journal-title":"Genes Canc."},{"issue":"18","key":"10.1016\/j.yexcr.2021.112755_bib31","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/onc.2016.401","article-title":"A redox state-dictated signalling pathway deciphers the malignant cell specificity of CD40-mediated apoptosis","volume":"36","author":"Dunnill","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2021.112755_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ijms19113657","article-title":"The regulation of JNK signaling pathways in cell death through the interplay with mitochondrial SAB and upstream post-translational effects","volume":"19","author":"Win","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.yexcr.2021.112755_bib33","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1159\/000369710","article-title":"Synergistic anticancer potential of dichloroacetate and estradiol analogue exerting their effect via ROS-JNK-Bcl-2-mediated signalling pathways","volume":"35","author":"Stander","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.yexcr.2021.112755_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41418-019-0486-3","article-title":"Saga of Mcl-1: regulation from transcription to degradation","volume":"27","author":"Senichkin","year":"2020","journal-title":"Cell Death Differ."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721003086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721003086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:37:52Z","timestamp":1757997472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721003086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0014482721003086"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112755","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112755"}}